Travelers Companies
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
149% more first-time investments, than exits
New positions opened: 217 | Existing positions closed: 87
27% more funds holding in top 10
Funds holding in top 10: 11 [Q3] → 14 (+3) [Q4]
15% more capital invested
Capital invested by funds: $46B [Q3] → $52.8B (+$6.79B) [Q4]
7% more funds holding
Funds holding: 1,443 [Q3] → 1,544 (+101) [Q4]
8% more call options, than puts
Call options by funds: $109M | Put options by funds: $101M
8% less repeat investments, than reductions
Existing positions increased: 499 | Existing positions reduced: 544
3.78% less ownership
Funds ownership: 86.91% [Q3] → 83.13% (-3.78%) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$225
14%
downside
Avg. target
$279
6%
upside
High target
$310
18%
upside
7 analyst ratings
5 positive
71%
1 neutral
14%
1 negative
14%
Keefe, Bruyette & Woods Meyer Shields 77% 1-year accuracy 85 / 111 met price target | 9%upside $286 | Outperform Upgraded | 19 Feb 2025 |
BMO Capital Michael Zaremski 86% 1-year accuracy 19 / 22 met price target | 13%upside $297 | Outperform Maintained | 24 Jan 2025 |
Barclays Alex Scott 53% 1-year accuracy 42 / 79 met price target | 10%upside $287 | Overweight Maintained | 24 Jan 2025 |
Piper Sandler Paul Newsome 91% 1-year accuracy 42 / 46 met price target | 18%upside $310 | Overweight Upgraded | 24 Jan 2025 |
RBC Capital Scott Heleniak 80% 1-year accuracy 37 / 46 met price target | 2%upside $268 | Sector Perform Reiterated | 23 Jan 2025 |
Financial journalist opinion
Based on 9 articles about TRV published over the past 30 days
Positive
Seeking Alpha
1 day ago
The Travelers Companies: Pricing Power Persists, Raising My Price Target
Travelers (TRV) remains a buy due to strong quarterly results, resilient performance, and favorable valuation despite recent market pressures and extreme weather events. TRV's Q4 non-GAAP EPS of $9.15 beat forecasts by $2.54, with revenue up 20% YoY, driven by strong homeowners insurance margins. Key risks include the financial impact of LA wildfires, macro uncertainties, and insurance inflation, but TRV's pricing power and technical chart are encouraging.
Positive
Zacks Investment Research
6 days ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Negative
Investors Business Daily
1 week ago
Travelers Stock Nears Buy Point, But The Company Faces A Profit Headwind
Travelers stock has held up relatively well in a declining stock market and is nearing a buy point. The post Travelers Stock Nears Buy Point, But The Company Faces A Profit Headwind appeared first on Investor's Business Daily.
Negative
Zacks Investment Research
1 week ago
TRV Stock Trades Near 52-Week High: Buy or Wait for a Pullback?
A decline in 2025's bottom-line projection and bearish analysts sentiment keep us cautious about Travelers at present.
Neutral
Business Wire
1 week ago
Travelers Schedules Conference Call to Review First Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--The Travelers Companies, Inc. (NYSE: TRV) will review its first quarter 2025 results at 9 a.m. ET on Wednesday, April 16, following the release of results earlier that morning. Investors can access the call via webcast at investor.travelers.com and by dialing 888-440-6281 within the United States or 646-960-0218 outside the United States. A slide presentation, statistical supplement and live audio broadcast will be available on the same website. Following the event, r.
Positive
Investors Business Daily
1 week ago
Dow Jones Insurance Giant Travelers, Warren Buffett Stock In Or Near Buy Zones
Dow Jones insurance giant Travelers and Warren Buffett stock Berkshire Hathaway are in or near buy zones Monday. The post Dow Jones Insurance Giant Travelers, Warren Buffett Stock In Or Near Buy Zones appeared first on Investor's Business Daily.
Positive
Zacks Investment Research
1 week ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Neutral
Business Wire
2 weeks ago
Travelers Offers New Product Liability Insurance for Life Sciences Companies
HARTFORD, Conn.--(BUSINESS WIRE)--The Travelers Companies, Inc. (NYSE: TRV) today introduced Travelers Synergy℠, a new customizable product liability coverage tailored to life sciences companies. The offering will help medical technology, pharmaceutical, biopharmaceutical and digital health companies with the costs of product-related claims. “Life sciences companies are dedicated to improving health care through innovation, and having liability coverage that addresses their individual needs can.
Neutral
Business Wire
3 weeks ago
Travelers Publishes Cyber Threat Report Highlighting an Increase in Ransomware Activity
HARTFORD, Conn.--(BUSINESS WIRE)--The Travelers Companies, Inc. (NYSE: TRV) today released its Q4 2024 Cyber Threat Report, highlighting an elevated level of ransomware activity. The report, based on data collected from ransomware leak sites, showed an increase in the number of organizations that fell victim last quarter to ransomware groups, which used repeatable attack methods, such as targeting virtual private network (VPN) accounts that had weak credentials and were not protected by multifa.
Negative
Zacks Investment Research
1 month ago
Markets Mostly Dip Red Late in Regular Trading
After the closing bell, Zoom shares are -4% and HIMS are trading -17% lower on Q4 earnings results.
Charts implemented using Lightweight Charts™